世界の閉塞性細気管支炎症候群市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Bronchiolitis Obliterans Syndrome Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-3944
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、98ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、閉塞性細気管支炎症候群の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（吸入式、経口式）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・閉塞性細気管支炎症候群の市場動向
・企業の競争状況、市場シェア
・閉塞性細気管支炎症候群の種類別市場規模と予測2016-2027（吸入式、経口式）
・閉塞性細気管支炎症候群の用途別市場規模と予測2016-2027（病院、診療所、その他）
・閉塞性細気管支炎症候群の北米市場規模2016-2027（アメリカ、カナダ）
・閉塞性細気管支炎症候群の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・閉塞性細気管支炎症候群のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・閉塞性細気管支炎症候群の中南米市場規模2016-2027（メキシコ、ブラジル）
・閉塞性細気管支炎症候群の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Breath Therapeutics、Genentech、Incyte Corporation、Mereo BioPharma、Altavant Sciences、Koutif Therapeutics）
・結論

Bronchiolitis obliterans may result from lung injury caused by a variety of different chemicals and respiratory infections. Inhaled chemicals known to irritate the lungs and lead to the condition include chlorine; ammonia; oxides of nitrogen or sulfur dioxide; welding fumes; or food flavoring fumes (such as diacetyl). Respiratory infections caused by a respiratory syncytial virus, adenovirus, or Mycoplasma pneumonia have been linked with the condition.

Market Analysis and Insights: Global Bronchiolitis Obliterans Syndrome Market
The global Bronchiolitis Obliterans Syndrome market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Bronchiolitis Obliterans Syndrome market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Bronchiolitis Obliterans Syndrome market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Bronchiolitis Obliterans Syndrome market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Bronchiolitis Obliterans Syndrome market.

Global Bronchiolitis Obliterans Syndrome Scope and Market Size
Bronchiolitis Obliterans Syndrome market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Bronchiolitis Obliterans Syndrome market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Inhalation
Oral

Segment by Application
Hospital
Clinic
Others

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Breath Therapeutics
Genentech
Incyte Corporation
Mereo BioPharma
Altavant Sciences
Koutif Therapeutics

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Bronchiolitis Obliterans Syndrome Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Inhalation
1.2.3 Oral
1.3 Market by Application
1.3.1 Global Bronchiolitis Obliterans Syndrome Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Bronchiolitis Obliterans Syndrome Market Perspective (2016-2027)
2.2 Bronchiolitis Obliterans Syndrome Growth Trends by Regions
2.2.1 Bronchiolitis Obliterans Syndrome Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Bronchiolitis Obliterans Syndrome Historic Market Share by Regions (2016-2021)
2.2.3 Bronchiolitis Obliterans Syndrome Forecasted Market Size by Regions (2022-2027)
2.3 Bronchiolitis Obliterans Syndrome Industry Dynamic
2.3.1 Bronchiolitis Obliterans Syndrome Market Trends
2.3.2 Bronchiolitis Obliterans Syndrome Market Drivers
2.3.3 Bronchiolitis Obliterans Syndrome Market Challenges
2.3.4 Bronchiolitis Obliterans Syndrome Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Bronchiolitis Obliterans Syndrome Players by Revenue
3.1.1 Global Top Bronchiolitis Obliterans Syndrome Players by Revenue (2016-2021)
3.1.2 Global Bronchiolitis Obliterans Syndrome Revenue Market Share by Players (2016-2021)
3.2 Global Bronchiolitis Obliterans Syndrome Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Bronchiolitis Obliterans Syndrome Revenue
3.4 Global Bronchiolitis Obliterans Syndrome Market Concentration Ratio
3.4.1 Global Bronchiolitis Obliterans Syndrome Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Bronchiolitis Obliterans Syndrome Revenue in 2020
3.5 Bronchiolitis Obliterans Syndrome Key Players Head office and Area Served
3.6 Key Players Bronchiolitis Obliterans Syndrome Product Solution and Service
3.7 Date of Enter into Bronchiolitis Obliterans Syndrome Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Bronchiolitis Obliterans Syndrome Breakdown Data by Type
4.1 Global Bronchiolitis Obliterans Syndrome Historic Market Size by Type (2016-2021)
4.2 Global Bronchiolitis Obliterans Syndrome Forecasted Market Size by Type (2022-2027)

5 Bronchiolitis Obliterans Syndrome Breakdown Data by Application
5.1 Global Bronchiolitis Obliterans Syndrome Historic Market Size by Application (2016-2021)
5.2 Global Bronchiolitis Obliterans Syndrome Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Bronchiolitis Obliterans Syndrome Market Size (2016-2027)
6.2 North America Bronchiolitis Obliterans Syndrome Market Size by Type
6.2.1 North America Bronchiolitis Obliterans Syndrome Market Size by Type (2016-2021)
6.2.2 North America Bronchiolitis Obliterans Syndrome Market Size by Type (2022-2027)
6.2.3 North America Bronchiolitis Obliterans Syndrome Market Size by Type (2016-2027)
6.3 North America Bronchiolitis Obliterans Syndrome Market Size by Application
6.3.1 North America Bronchiolitis Obliterans Syndrome Market Size by Application (2016-2021)
6.3.2 North America Bronchiolitis Obliterans Syndrome Market Size by Application (2022-2027)
6.3.3 North America Bronchiolitis Obliterans Syndrome Market Size by Application (2016-2027)
6.4 North America Bronchiolitis Obliterans Syndrome Market Size by Country
6.4.1 North America Bronchiolitis Obliterans Syndrome Market Size by Country (2016-2021)
6.4.2 North America Bronchiolitis Obliterans Syndrome Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Bronchiolitis Obliterans Syndrome Market Size (2016-2027)
7.2 Europe Bronchiolitis Obliterans Syndrome Market Size by Type
7.2.1 Europe Bronchiolitis Obliterans Syndrome Market Size by Type (2016-2021)
7.2.2 Europe Bronchiolitis Obliterans Syndrome Market Size by Type (2022-2027)
7.2.3 Europe Bronchiolitis Obliterans Syndrome Market Size by Type (2016-2027)
7.3 Europe Bronchiolitis Obliterans Syndrome Market Size by Application
7.3.1 Europe Bronchiolitis Obliterans Syndrome Market Size by Application (2016-2021)
7.3.2 Europe Bronchiolitis Obliterans Syndrome Market Size by Application (2022-2027)
7.3.3 Europe Bronchiolitis Obliterans Syndrome Market Size by Application (2016-2027)
7.4 Europe Bronchiolitis Obliterans Syndrome Market Size by Country
7.4.1 Europe Bronchiolitis Obliterans Syndrome Market Size by Country (2016-2021)
7.4.2 Europe Bronchiolitis Obliterans Syndrome Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Bronchiolitis Obliterans Syndrome Market Size (2016-2027)
8.2 Asia-Pacific Bronchiolitis Obliterans Syndrome Market Size by Type
8.2.1 Asia-Pacific Bronchiolitis Obliterans Syndrome Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Bronchiolitis Obliterans Syndrome Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Bronchiolitis Obliterans Syndrome Market Size by Type (2016-2027)
8.3 Asia-Pacific Bronchiolitis Obliterans Syndrome Market Size by Application
8.3.1 Asia-Pacific Bronchiolitis Obliterans Syndrome Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Bronchiolitis Obliterans Syndrome Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Bronchiolitis Obliterans Syndrome Market Size by Application (2016-2027)
8.4 Asia-Pacific Bronchiolitis Obliterans Syndrome Market Size by Region
8.4.1 Asia-Pacific Bronchiolitis Obliterans Syndrome Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Bronchiolitis Obliterans Syndrome Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Bronchiolitis Obliterans Syndrome Market Size (2016-2027)
9.2 Latin America Bronchiolitis Obliterans Syndrome Market Size by Type
9.2.1 Latin America Bronchiolitis Obliterans Syndrome Market Size by Type (2016-2021)
9.2.2 Latin America Bronchiolitis Obliterans Syndrome Market Size by Type (2022-2027)
9.2.3 Latin America Bronchiolitis Obliterans Syndrome Market Size by Type (2016-2027)
9.3 Latin America Bronchiolitis Obliterans Syndrome Market Size by Application
9.3.1 Latin America Bronchiolitis Obliterans Syndrome Market Size by Application (2016-2021)
9.3.2 Latin America Bronchiolitis Obliterans Syndrome Market Size by Application (2022-2027)
9.3.3 Latin America Bronchiolitis Obliterans Syndrome Market Size by Application (2016-2027)
9.4 Latin America Bronchiolitis Obliterans Syndrome Market Size by Country
9.4.1 Latin America Bronchiolitis Obliterans Syndrome Market Size by Country (2016-2021)
9.4.2 Latin America Bronchiolitis Obliterans Syndrome Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Bronchiolitis Obliterans Syndrome Market Size (2016-2027)
10.2 Middle East & Africa Bronchiolitis Obliterans Syndrome Market Size by Type
10.2.1 Middle East & Africa Bronchiolitis Obliterans Syndrome Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Bronchiolitis Obliterans Syndrome Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Bronchiolitis Obliterans Syndrome Market Size by Type (2016-2027)
10.3 Middle East & Africa Bronchiolitis Obliterans Syndrome Market Size by Application
10.3.1 Middle East & Africa Bronchiolitis Obliterans Syndrome Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Bronchiolitis Obliterans Syndrome Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Bronchiolitis Obliterans Syndrome Market Size by Application (2016-2027)
10.4 Middle East & Africa Bronchiolitis Obliterans Syndrome Market Size by Country
10.4.1 Middle East & Africa Bronchiolitis Obliterans Syndrome Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Bronchiolitis Obliterans Syndrome Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Breath Therapeutics
11.1.1 Breath Therapeutics Company Details
11.1.2 Breath Therapeutics Business Overview
11.1.3 Breath Therapeutics Bronchiolitis Obliterans Syndrome Introduction
11.1.4 Breath Therapeutics Revenue in Bronchiolitis Obliterans Syndrome Business (2016-2021)
11.1.5 Breath Therapeutics Recent Development
11.2 Genentech
11.2.1 Genentech Company Details
11.2.2 Genentech Business Overview
11.2.3 Genentech Bronchiolitis Obliterans Syndrome Introduction
11.2.4 Genentech Revenue in Bronchiolitis Obliterans Syndrome Business (2016-2021)
11.2.5 Genentech Recent Development
11.3 Incyte Corporation
11.3.1 Incyte Corporation Company Details
11.3.2 Incyte Corporation Business Overview
11.3.3 Incyte Corporation Bronchiolitis Obliterans Syndrome Introduction
11.3.4 Incyte Corporation Revenue in Bronchiolitis Obliterans Syndrome Business (2016-2021)
11.3.5 Incyte Corporation Recent Development
11.4 Mereo BioPharma
11.4.1 Mereo BioPharma Company Details
11.4.2 Mereo BioPharma Business Overview
11.4.3 Mereo BioPharma Bronchiolitis Obliterans Syndrome Introduction
11.4.4 Mereo BioPharma Revenue in Bronchiolitis Obliterans Syndrome Business (2016-2021)
11.4.5 Mereo BioPharma Recent Development
11.5 Altavant Sciences
11.5.1 Altavant Sciences Company Details
11.5.2 Altavant Sciences Business Overview
11.5.3 Altavant Sciences Bronchiolitis Obliterans Syndrome Introduction
11.5.4 Altavant Sciences Revenue in Bronchiolitis Obliterans Syndrome Business (2016-2021)
11.5.5 Altavant Sciences Recent Development
11.6 Koutif Therapeutics
11.6.1 Koutif Therapeutics Company Details
11.6.2 Koutif Therapeutics Business Overview
11.6.3 Koutif Therapeutics Bronchiolitis Obliterans Syndrome Introduction
11.6.4 Koutif Therapeutics Revenue in Bronchiolitis Obliterans Syndrome Business (2016-2021)
11.6.5 Koutif Therapeutics Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Bronchiolitis Obliterans Syndrome Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Inhalation
Table 3. Key Players of Oral
Table 4. Global Bronchiolitis Obliterans Syndrome Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Bronchiolitis Obliterans Syndrome Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Bronchiolitis Obliterans Syndrome Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Bronchiolitis Obliterans Syndrome Market Share by Regions (2016-2021)
Table 8. Global Bronchiolitis Obliterans Syndrome Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Bronchiolitis Obliterans Syndrome Market Share by Regions (2022-2027)
Table 10. Bronchiolitis Obliterans Syndrome Market Trends
Table 11. Bronchiolitis Obliterans Syndrome Market Drivers
Table 12. Bronchiolitis Obliterans Syndrome Market Challenges
Table 13. Bronchiolitis Obliterans Syndrome Market Restraints
Table 14. Global Bronchiolitis Obliterans Syndrome Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Bronchiolitis Obliterans Syndrome Market Share by Players (2016-2021)
Table 16. Global Top Bronchiolitis Obliterans Syndrome Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bronchiolitis Obliterans Syndrome as of 2020)
Table 17. Ranking of Global Top Bronchiolitis Obliterans Syndrome Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Bronchiolitis Obliterans Syndrome Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Bronchiolitis Obliterans Syndrome Product Solution and Service
Table 21. Date of Enter into Bronchiolitis Obliterans Syndrome Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Bronchiolitis Obliterans Syndrome Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Bronchiolitis Obliterans Syndrome Revenue Market Share by Type (2016-2021)
Table 25. Global Bronchiolitis Obliterans Syndrome Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Bronchiolitis Obliterans Syndrome Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Bronchiolitis Obliterans Syndrome Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Bronchiolitis Obliterans Syndrome Revenue Market Share by Application (2016-2021)
Table 29. Global Bronchiolitis Obliterans Syndrome Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Bronchiolitis Obliterans Syndrome Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Bronchiolitis Obliterans Syndrome Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Bronchiolitis Obliterans Syndrome Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Bronchiolitis Obliterans Syndrome Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Bronchiolitis Obliterans Syndrome Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Bronchiolitis Obliterans Syndrome Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Bronchiolitis Obliterans Syndrome Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Bronchiolitis Obliterans Syndrome Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Bronchiolitis Obliterans Syndrome Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Bronchiolitis Obliterans Syndrome Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Bronchiolitis Obliterans Syndrome Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Bronchiolitis Obliterans Syndrome Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Bronchiolitis Obliterans Syndrome Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Bronchiolitis Obliterans Syndrome Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Bronchiolitis Obliterans Syndrome Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Bronchiolitis Obliterans Syndrome Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Bronchiolitis Obliterans Syndrome Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Bronchiolitis Obliterans Syndrome Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Bronchiolitis Obliterans Syndrome Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Bronchiolitis Obliterans Syndrome Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Bronchiolitis Obliterans Syndrome Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Bronchiolitis Obliterans Syndrome Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Bronchiolitis Obliterans Syndrome Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Bronchiolitis Obliterans Syndrome Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Bronchiolitis Obliterans Syndrome Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Bronchiolitis Obliterans Syndrome Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Bronchiolitis Obliterans Syndrome Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Bronchiolitis Obliterans Syndrome Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Bronchiolitis Obliterans Syndrome Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Bronchiolitis Obliterans Syndrome Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Bronchiolitis Obliterans Syndrome Market Size by Country (2022-2027) & (US$ Million)
Table 61. Breath Therapeutics Company Details
Table 62. Breath Therapeutics Business Overview
Table 63. Breath Therapeutics Bronchiolitis Obliterans Syndrome Product
Table 64. Breath Therapeutics Revenue in Bronchiolitis Obliterans Syndrome Business (2016-2021) & (US$ Million)
Table 65. Breath Therapeutics Recent Development
Table 66. Genentech Company Details
Table 67. Genentech Business Overview
Table 68. Genentech Bronchiolitis Obliterans Syndrome Product
Table 69. Genentech Revenue in Bronchiolitis Obliterans Syndrome Business (2016-2021) & (US$ Million)
Table 70. Genentech Recent Development
Table 71. Incyte Corporation Company Details
Table 72. Incyte Corporation Business Overview
Table 73. Incyte Corporation Bronchiolitis Obliterans Syndrome Product
Table 74. Incyte Corporation Revenue in Bronchiolitis Obliterans Syndrome Business (2016-2021) & (US$ Million)
Table 75. Incyte Corporation Recent Development
Table 76. Mereo BioPharma Company Details
Table 77. Mereo BioPharma Business Overview
Table 78. Mereo BioPharma Bronchiolitis Obliterans Syndrome Product
Table 79. Mereo BioPharma Revenue in Bronchiolitis Obliterans Syndrome Business (2016-2021) & (US$ Million)
Table 80. Mereo BioPharma Recent Development
Table 81. Altavant Sciences Company Details
Table 82. Altavant Sciences Business Overview
Table 83. Altavant Sciences Bronchiolitis Obliterans Syndrome Product
Table 84. Altavant Sciences Revenue in Bronchiolitis Obliterans Syndrome Business (2016-2021) & (US$ Million)
Table 85. Altavant Sciences Recent Development
Table 86. Koutif Therapeutics Company Details
Table 87. Koutif Therapeutics Business Overview
Table 88. Koutif Therapeutics Bronchiolitis Obliterans Syndrome Product
Table 89. Koutif Therapeutics Revenue in Bronchiolitis Obliterans Syndrome Business (2016-2021) & (US$ Million)
Table 90. Koutif Therapeutics Recent Development
Table 91. Research Programs/Design for This Report
Table 92. Key Data Information from Secondary Sources
Table 93. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Bronchiolitis Obliterans Syndrome Market Share by Type: 2020 VS 2027
Figure 2. Inhalation Features
Figure 3. Oral Features
Figure 4. Global Bronchiolitis Obliterans Syndrome Market Share by Application: 2020 VS 2027
Figure 5. Hospital Case Studies
Figure 6. Clinic Case Studies
Figure 7. Others Case Studies
Figure 8. Bronchiolitis Obliterans Syndrome Report Years Considered
Figure 9. Global Bronchiolitis Obliterans Syndrome Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Bronchiolitis Obliterans Syndrome Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Bronchiolitis Obliterans Syndrome Market Share by Regions: 2020 VS 2027
Figure 12. Global Bronchiolitis Obliterans Syndrome Market Share by Regions (2022-2027)
Figure 13. Global Bronchiolitis Obliterans Syndrome Market Share by Players in 2020
Figure 14. Global Top Bronchiolitis Obliterans Syndrome Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bronchiolitis Obliterans Syndrome as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Bronchiolitis Obliterans Syndrome Revenue in 2020
Figure 16. Global Bronchiolitis Obliterans Syndrome Revenue Market Share by Type (2016-2021)
Figure 17. Global Bronchiolitis Obliterans Syndrome Revenue Market Share by Type (2022-2027)
Figure 18. North America Bronchiolitis Obliterans Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Bronchiolitis Obliterans Syndrome Market Share by Type (2016-2027)
Figure 20. North America Bronchiolitis Obliterans Syndrome Market Share by Application (2016-2027)
Figure 21. North America Bronchiolitis Obliterans Syndrome Market Share by Country (2016-2027)
Figure 22. United States Bronchiolitis Obliterans Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Bronchiolitis Obliterans Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Bronchiolitis Obliterans Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Bronchiolitis Obliterans Syndrome Market Share by Type (2016-2027)
Figure 26. Europe Bronchiolitis Obliterans Syndrome Market Share by Application (2016-2027)
Figure 27. Europe Bronchiolitis Obliterans Syndrome Market Share by Country (2016-2027)
Figure 28. Germany Bronchiolitis Obliterans Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Bronchiolitis Obliterans Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Bronchiolitis Obliterans Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Bronchiolitis Obliterans Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Bronchiolitis Obliterans Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Bronchiolitis Obliterans Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Bronchiolitis Obliterans Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Bronchiolitis Obliterans Syndrome Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Bronchiolitis Obliterans Syndrome Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Bronchiolitis Obliterans Syndrome Market Share by Region (2016-2027)
Figure 38. China Bronchiolitis Obliterans Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Bronchiolitis Obliterans Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Bronchiolitis Obliterans Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Bronchiolitis Obliterans Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Bronchiolitis Obliterans Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Bronchiolitis Obliterans Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Bronchiolitis Obliterans Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Bronchiolitis Obliterans Syndrome Market Share by Type (2016-2027)
Figure 46. Latin America Bronchiolitis Obliterans Syndrome Market Share by Application (2016-2027)
Figure 47. Latin America Bronchiolitis Obliterans Syndrome Market Share by Country (2016-2027)
Figure 48. Mexico Bronchiolitis Obliterans Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Bronchiolitis Obliterans Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Bronchiolitis Obliterans Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Bronchiolitis Obliterans Syndrome Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Bronchiolitis Obliterans Syndrome Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Bronchiolitis Obliterans Syndrome Market Share by Country (2016-2027)
Figure 54. Turkey Bronchiolitis Obliterans Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Bronchiolitis Obliterans Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Bronchiolitis Obliterans Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Breath Therapeutics Revenue Growth Rate in Bronchiolitis Obliterans Syndrome Business (2016-2021)
Figure 58. Genentech Revenue Growth Rate in Bronchiolitis Obliterans Syndrome Business (2016-2021)
Figure 59. Incyte Corporation Revenue Growth Rate in Bronchiolitis Obliterans Syndrome Business (2016-2021)
Figure 60. Mereo BioPharma Revenue Growth Rate in Bronchiolitis Obliterans Syndrome Business (2016-2021)
Figure 61. Altavant Sciences Revenue Growth Rate in Bronchiolitis Obliterans Syndrome Business (2016-2021)
Figure 62. Koutif Therapeutics Revenue Growth Rate in Bronchiolitis Obliterans Syndrome Business (2016-2021)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed

以下、関連資料のご紹介

世界の肝腎症候群治療市場規模・現状・予測（2021年-2027年）

Global Hepatorenal Syndrome Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4305 2021年6月 88Pages
QYResearch社発行の本調査レポートでは、肝腎症候群治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ヘパトレン、テルリバズ、グリプレシン、ルカシン、その他）、用途別市場規模（1型肝腎症候群、2型肝腎症候群）、主要地域別市場規模（北米、アメ...

世界のアッシャー症候群治療薬市場規模・現状・予測（2021年-2027年）

Global Usher Syndrome Threapeutics Market Size, Status and Forecast 2021-2027
QFJ1-5003 2021年6月 87Pages
QYResearch社発行の本調査レポートでは、アッシャー症候群治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（NT-501、QRX-411、QRX-421、SAR-421869、その他）、用途別市場規模（クリニック、病院、その他）、主要地域...

世界のウェスト症候群市場規模・現状・予測（2021年-2027年）

Global West Syndrome Market Size, Status and Forecast 2021-2027
QFJ1-5039 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、ウェスト症候群の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（治療法、新薬）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東...

世界の骨髄異形成症候群分子診断市場規模・現状・予測（2021年-2027年）

Global Molecular Diagnosis of Myelodysplastic Syndrome Market Size, Status and Forecast 2021-2027
QFJ1-4519 2021年6月 88Pages
QYResearch社発行の本調査レポートでは、骨髄異形成症候群分子診断の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（PCR、FISH、DNAシーケンシング、ジーンチップ）、用途別市場規模（臨床診断、薬物スクリーニング、研究）、主要地域別市場規模...

世界のブルガダ症候群市場規模・現状・予測（2021年-2027年）

Global Brugada Syndrome Market Size, Status and Forecast 2021-2027
QFJ1-5638 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、ブルガダ症候群の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（診断、治療）、用途別市場規模（大人、子供）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米...

世界の過敏性腸症候群（IBS）処方薬市場規模・現状・予測（2021年-2027年）

Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Size, Status and Forecast 2021-2027
QFJ1-6000 2021年6月 100Pages
QYResearch社発行の本調査レポートでは、過敏性腸症候群（IBS）処方薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（IBS-D薬、IBS-C薬、その他）、用途別市場規模（女性用、男性用）、主要地域別市場規模（北米、アメリカ、欧州、アジア、...

世界のレノックス・ガストー症候群治療市場規模・現状・予測（2021年-2027年）

Global Lennox-Gastaut Syndrome Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4422 2021年6月 100Pages
QYResearch社発行の本調査レポートでは、レノックス・ガストー症候群治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（非外科的治療、外科的治療）、用途別市場規模（発作、眼球異常、脳波所見、その他）、主要地域別市場規模（北米、アメリカ、欧州、...

世界のダンピング症候群治療市場規模・現状・予測（2021年-2027年）

Global Dumping Syndrome Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4163 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、ダンピング症候群治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（医療、外科療法）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド...

世界のグッドパスチャー症候群治療市場規模・現状・予測（2021年-2027年）

Global Goodpasture Syndrome Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5758 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、グッドパスチャー症候群治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（コルチコステロイド、免疫抑制剤、その他）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、ア...

世界のレット症候群治療市場規模・現状・予測（2021年-2027年）

Global Rett Syndrome Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5994 2021年6月 95Pages
QYResearch社発行の本調査レポートでは、レット症候群治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（抗てんかん薬、抗てんかん薬、鎮静催眠薬、その他）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、...

世界のアッシャー症候群治療薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Usher Syndrome Threapeutics Market The global Usher Syndrome Threapeutics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity…
世界のウェスト症候群市場規模・現状・予測（2021年-2027年） West syndrome is an age-related specific epileptic encephalopathy due to multiple and diverse causes. It is characterized by a unique type of seizure called epileptic (infantile) spasms and gross EEG abnormalities of hypsarrhythmia. Usually, West syndrome consists of a characteristic triad: infantil…
世界の肝腎症候群治療市場規模・現状・予測（2021年-2027年） Hepatorenal syndrome (often abbreviated HRS) is a life-threatening medical condition that consists of rapid deterioration in kidney function in individuals with cirrhosis or fulminant liver failure. HRS is usually fatal unless a liver transplant is performed, although various treatments, such as dia…
世界のグッドパスチャー症候群治療市場規模・現状・予測（2021年-2027年） Goodpasture syndrome may be caused by viral infection and / or inhalation of certain chemical substances causing primary lung damage. Market Analysis and Insights: Global Goodpasture Syndrome Treatment Market The global Goodpasture Syndrome Treatment market size is projected to reach US$ XX million …
世界の骨髄異形成症候群分子診断市場規模・現状・予測（2021年-2027年） A diagnostic method for myelodysplastic syndrome Market Analysis and Insights: Global Molecular Diagnosis of Myelodysplastic Syndrome Market The global Molecular Diagnosis of Myelodysplastic Syndrome market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of …